Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 168937, 10 pages
http://dx.doi.org/10.1155/2015/168937
Review Article

Endothelial-Leukocyte Interaction in Severe Malaria: Beyond the Brain

1Laboratory of Applied Pharmacology, Farmanguinhos, Oswaldo Cruz Foundation, Avenida Brasil 4365, Manguinhos, 21040-900 Rio de Janeiro, RJ, Brazil
2National Institute for Science and Technology on Innovation on Neglected Diseases (INCT/IDN), Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil

Received 19 June 2015; Revised 25 August 2015; Accepted 1 September 2015

Academic Editor: Pilar Alcaide

Copyright © 2015 Mariana C. Souza et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, “WHO guidelines approved by the guidelines review committee,” in Guidelines for the Treatment of Malaria, World Health Organization, Geneva, Switzerland, 2015. View at Google Scholar
  2. C. Murray and R. Chambers, “Keeping score: fostering accountability for children's lives,” The Lancet, vol. 386, no. 9988, pp. 3–5, 2015. View at Publisher · View at Google Scholar
  3. K. B. Seydel, S. D. Kampondeni, C. Valim et al., “Brain swelling and death in children with cerebral malaria,” The New England Journal of Medicine, vol. 372, no. 12, pp. 1126–1137, 2015. View at Publisher · View at Google Scholar
  4. H. Kim, S. Higgins, W. C. Liles, and K. C. Kain, “Endothelial activation and dysregulation in malaria: a potential target for novel therapeutics,” Current Opinion in Hematology, vol. 18, no. 3, pp. 177–185, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. S. C. Wassmer, T. E. Taylor, P. K. Rathod et al., “Investigating the pathogenesis of severe malaria: a multidisciplinary and cross-geographical approach,” The American Journal of Tropical Medicine and Hygiene, vol. 93, no. 3, supplement, pp. 42–56, 2015. View at Publisher · View at Google Scholar
  6. T. E. Taylor and M. E. Molyneux, “The pathogenesis of pediatric cerebral malaria: eye exams, autopsies, and neuroimaging,” Annals of the New York Academy of Sciences, vol. 1342, no. 1, pp. 44–52, 2015. View at Publisher · View at Google Scholar
  7. A. Mohan, S. K. Sharma, and S. Bollineni, “Acute lung injury and acute respiratory distress syndrome in malaria,” Journal of Vector Borne Diseases, vol. 45, no. 3, pp. 179–193, 2008. View at Google Scholar · View at Scopus
  8. J. Abdul Manan, H. Ali, and M. Lal, “Acute renal failure associated with malaria,” Journal of Ayub Medical College, Abbottabad, vol. 18, no. 4, pp. 47–52, 2006. View at Google Scholar · View at Scopus
  9. W. R. J. Taylor, J. Hanson, G. D. H. Turner, N. J. White, and A. M. Dondorp, “Respiratory manifestations of malaria,” Chest, vol. 142, no. 2, pp. 492–505, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. G. P. Maguire, T. Handojo, M. C. F. Pain et al., “Lung injury in uncomplicated and severe falciparum malaria: a longitudinal study in Papua, Indonesia,” Journal of Infectious Diseases, vol. 192, no. 11, pp. 1966–1974, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Milner Jr., R. Factor, R. Whitten et al., “Pulmonary pathology in pediatric cerebral malaria,” Human Pathology, vol. 44, no. 12, pp. 2719–2726, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. D. A. Milner Jr., R. O. Whitten, S. Kamiza et al., “The systemic pathology of cerebral malaria in African children,” Frontiers in Cellular and Infection Microbiology, vol. 4, article 104, 2014. View at Publisher · View at Google Scholar
  13. M. G. Harris, P. Hulseberg, C. Ling et al., “Immune privilege of the CNS is not the consequence of limited antigen sampling,” Scientific Reports, vol. 4, article 4422, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Alfieri, S. Srivastava, R. C. M. Siow et al., “Sulforaphane preconditioning of the Nrf2/HO-1 defense pathway protects the cerebral vasculature against blood-brain barrier disruption and neurological deficits in stroke,” Free Radical Biology and Medicine, vol. 65, pp. 1012–1022, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. N. M. Silva, R. M. Manzan, W. P. Carneiro et al., “Toxoplasma gondii: the severity of toxoplasmic encephalitis in C57BL/6 mice is associated with increased ALCAM and VCAM-1 expression in the central nervous system and higher blood-brain barrier permeability,” Experimental Parasitology, vol. 126, no. 2, pp. 167–177, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Dorovini-Zis, K. Schmidt, H. Huynh et al., “The neuropathology of fatal cerebral malaria in Malawian children,” The American Journal of Pathology, vol. 178, no. 5, pp. 2146–2158, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. G. G. MacPherson, M. J. Warrell, N. J. White, and S. Looareesuwan, “Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration,” The American Journal of Pathology, vol. 119, no. 3, pp. 385–401, 1985. View at Google Scholar · View at Scopus
  18. L. Turner, T. Lavstsen, S. S. Berger et al., “Severe malaria is associated with parasite binding to endothelial protein C receptor,” Nature, vol. 498, no. 7455, pp. 502–505, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. J. K. Patnaik, B. S. Das, S. K. Mishra, S. Mohanty, S. K. Satpathy, and D. Mohanty, “Vascular clogging, mononuclear cell margination, and enhanced vascular permeability in the pathogenesis of human cerebral malaria,” American Journal of Tropical Medicine and Hygiene, vol. 51, no. 5, pp. 642–647, 1994. View at Google Scholar · View at Scopus
  20. C. Punsawad, Y. Maneerat, U. Chaisri, K. Nantavisai, and P. Viriyavejakul, “Nuclear factor kappa B modulates apoptosis in the brain endothelial cells and intravascular leukocytes of fatal cerebral malaria,” Malaria Journal, vol. 12, article 260, 12 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. F. García, M. Cebrián, M. Dgedge et al., “Endothelial cell activation in muscle biopsy samples is related to clinical severity in human cerebral malaria,” The Journal of Infectious Diseases, vol. 179, no. 2, pp. 475–483, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Krupka, K. Seydel, C. M. Feintuch et al., “Mild Plasmodium falciparum malaria following an episode of severe malaria is associated with induction of the interferon pathway in Malawian children,” Infection and Immunity, vol. 80, no. 3, pp. 1150–1155, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Worku, M. Troye-Blomberg, B. Christensson, A. Björkman, and T. Fehniger, “Activation of T cells in the blood of patients with acute malaria: proliferative activity as indicated by Ki-67 expression,” Scandinavian Journal of Immunology, vol. 53, no. 3, pp. 296–301, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. A. L. Conroy, S. J. Glover, M. Hawkes et al., “Angiopoietin-2 levels are associated with retinopathy and predict mortality in Malawian children with cerebral malaria: a retrospective case-control study,” Critical Care Medicine, vol. 40, no. 3, pp. 952–959, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. V. Jain, N. W. Lucchi, N. O. Wilson et al., “Plasma levels of angiopoietin-1 and -2 predict cerebral malaria outcome in Central India,” Malaria Journal, vol. 10, article 383, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Prato, S. D'Alessandro, P. E. Van den Steen et al., “Natural haemozoin modulates matrix metalloproteinases and induces morphological changes in human microvascular endothelium,” Cellular Microbiology, vol. 13, no. 8, pp. 1275–1285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. S. D. Tachado, P. Gerold, M. J. McConville et al., “Glycosylphosphatidylinositol toxin of Plasmodium induces nitric oxide synthase expression in macrophages and vascular endothelial cells by a protein tyrosine kinase-dependent and protein kinase C-dependent signaling pathway,” Journal of Immunology, vol. 156, no. 5, pp. 1897–1907, 1996. View at Google Scholar · View at Scopus
  28. H. Armah, E. K. Wiredu, A. K. Dodoo, A. A. Adjei, Y. Tettey, and R. Gyasi, “Cytokines and adhesion molecules expression in the brain in human cerebral malaria,” International Journal of Environmental Research and Public Health, vol. 2, no. 1, pp. 123–131, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Brown, T. T. Hien, N. Day et al., “Evidence of blood-brain barrier dysfunction in human cerebral malaria,” Neuropathology and Applied Neurobiology, vol. 25, no. 4, pp. 331–340, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Wu, T. Szestak, M. Stins, and A. G. Craig, “Amplification of P. falciparum cytoadherence through induction of a pro-adhesive state in host endothelium,” PLoS ONE, vol. 6, no. 10, Article ID e24784, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Storm and A. G. Craig, “Pathogenesis of cerebral malariaâ—inflammation and cytoadherence,” Frontiers in Cellular and Infection Microbiology, vol. 4, article 100, 2014. View at Publisher · View at Google Scholar
  32. S. J. Chakravorty, C. Carret, G. B. Nash, A. Ivens, T. Szestak, and A. G. Craig, “Altered phenotype and gene transcription in endothelial cells, induced by Plasmodium falciparum-infected red blood cells: pathogenic or protective?” International Journal for Parasitology, vol. 37, no. 8-9, pp. 975–987, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. M. C. Souza, T. A. Pádua, N. D. Torres et al., “Lipoxin A4 attenuates endothelial dysfunction during experimental cerebral malaria,” International Immunopharmacology, vol. 24, no. 2, pp. 400–407, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Nacer, A. Movila, F. Sohet et al., “Experimental cerebral malaria pathogenesis—hemodynamics at the blood brain barrier,” PLoS Pathogens, vol. 10, no. 12, Article ID e1004528, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Pai, J. Qin, L. Cavanagh et al., “Real-time imaging reveals the dynamics of leukocyte behaviour during experimental cerebral malaria pathogenesis,” PLoS Pathogens, vol. 10, no. 7, Article ID e1004236, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Nacer, A. Movila, K. Baer, S. A. Mikolajczak, S. H. I. Kappe, and U. Frevert, “Neuroimmunological blood brain barrier opening in experimental cerebral malaria,” PLoS Pathogens, vol. 8, no. 10, Article ID e1002982, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. U. Frevert, A. Nacer, M. Cabrera, A. Movila, and M. Leberl, “Imaging Plasmodium immunobiology in the liver, brain, and lung,” Parasitology International, vol. 63, no. 1, pp. 171–186, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. G. Senaldi, C. Vesin, R. Chang, G. E. Grau, and P. F. Piguet, “Role of polymorphonuclear neutrophil leukocytes and their integrin CD11a (LFA-1) in the pathogenesis of severe murine malaria,” Infection and Immunity, vol. 62, no. 4, pp. 1144–1149, 1994. View at Google Scholar · View at Scopus
  39. T. N. Ramos, D. C. Bullard, M. M. Darley, K. McDonald, D. F. Crawford, and S. R. Barnum, “Experimental cerebral malaria develops independently of endothelial expression of intercellular adhesion molecule-1 (ICAM-1),” The Journal of Biological Chemistry, vol. 288, no. 16, pp. 10962–10966, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Jambou, V. Combes, M.-J. Jambou, B. B. Weksler, P.-O. Couraud, and G. E. Grau, “Plasmodium falciparum adhesion on human brain microvascular endothelial cells involves transmigration-like cup formation and induces opening of intercellular junctions,” PLoS Pathogens, vol. 6, no. 7, Article ID e1001021, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. S. W. Howland, C. M. Poh, L. Rénia, and J. Langhorne, “Activated brain endothelial cells cross-present malaria antigen,” PLOS Pathogens, vol. 11, no. 6, Article ID e1004963, 2015. View at Publisher · View at Google Scholar
  42. T. Owens, I. Bechmann, and B. Engelhardt, “Perivascular spaces and the two steps to neuroinflammation,” Journal of Neuropathology & Experimental Neurology, vol. 67, no. 12, pp. 1113–1121, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Louveau, I. Smirnov, T. J. Keyes et al., “Structural and functional features of central nervous system lymphatic vessels,” Nature, vol. 523, no. 7560, pp. 337–341, 2015. View at Publisher · View at Google Scholar
  44. A. J. Sweatt and J. E. Levitt, “Evolving epidemiology and definitions of the acute respiratory distress syndrome and early acute lung injury,” Clinics in Chest Medicine, vol. 35, no. 4, pp. 609–624, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. M. C. Souza, J. D. Silva, T. A. Pádua, V. L. Capelozzi, P. R. M. Rocco, and M. D. G. Henriques, “Early and late acute lung injury and their association with distal organ damage in murine malaria,” Respiratory Physiology & Neurobiology, vol. 186, no. 1, pp. 65–72, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. E. H. Aitken, E. M. Negri, R. Barboza et al., “Ultrastructure of the lung in a murine model of malaria-associated acute lung injury/acute respiratory distress syndrome,” Malaria Journal, vol. 13, article 230, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Epiphanio, M. G. Campos, A. Pamplona et al., “VEGF promotes malaria-associated acute lung injury in mice,” PLoS Pathogens, vol. 6, no. 5, Article ID e1000916, 2010. View at Google Scholar · View at Scopus
  48. L. S. Ortolan, M. K. Sercundes, R. Barboza et al., “Predictive criteria to study the pathogenesis of malaria-associated ALI/ARDS in mice,” Mediators of Inflammation, vol. 2014, Article ID 872464, 12 pages, 2014. View at Publisher · View at Google Scholar
  49. F. E. Lovegrove, L. Peña-Castillo, N. Mohammad, W. C. Liles, T. R. Hughes, and K. C. Kain, “Simultaneous host and parasite expression profiling identifies tissue-specific transcriptional programs associated with susceptibility or resistance to experimental cerebral malaria,” BMC Genomics, vol. 7, article 295, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. K. Baer, C. Klotz, S. H. I. Kappe, T. Schnieder, and U. Frevert, “Release of hepatic Plasmodium yoelii merozoites into the pulmonary microvasculature,” PLoS Pathogens, vol. 3, article e171, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Thiberge, S. Blazquez, P. Baldacci et al., “In vivo imaging of malaria parasites in the murine liver,” Nature Protocols, vol. 2, no. 7, pp. 1811–1818, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Deroost, A. Tyberghein, N. Lays et al., “Hemozoin induces lung inflammation and correlates with malaria-associated acute respiratory distress syndrome,” American Journal of Respiratory Cell and Molecular Biology, vol. 48, no. 5, pp. 589–600, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. P. E. Van den Steen, N. Geurts, K. Deroost et al., “Immunopathology and dexamethasone therapy in a new model for malaria-associated acute respiratory distress syndrome,” American Journal of Respiratory and Critical Care Medicine, vol. 181, no. 9, pp. 957–968, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. E. Belnoue, S. M. Potter, D. S. Rosa et al., “Control of pathogenic CD8+ T cell migration to the brain by IFN-gamma during experimental cerebral malaria,” Parasite Immunology, vol. 30, no. 10, pp. 544–553, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. M. R. Looney, E. E. Thornton, D. Sen, W. J. Lamm, R. W. Glenny, and M. F. Krummel, “Stabilized imaging of immune surveillance in the mouse lung,” Nature Methods, vol. 8, no. 1, pp. 91–96, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. V. R. Krishnamurthy, M. Y. Sardar, Y. Ying et al., “Glycopeptide analogues of PSGL-1 inhibit P-selectin in vitro and in vivo,” Nature Communications, vol. 6, article 6387, 2015. View at Publisher · View at Google Scholar
  57. C. R. Parish, “The role of heparan sulphate in inflammation,” Nature Reviews Immunology, vol. 6, no. 9, pp. 633–643, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. V. Combes, A. R. Rosenkranz, M. Redard et al., “athogenic role of P-selectin in experimental cerebral malaria: importance of the endothelial compartment,” American Journal of Pathology, vol. 164, no. 3, pp. 781–786, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. N. Favre, C. da Laperousaz, B. Ryffel et al., “Role of ICAM-1 (CD54) in the development of murine cerebral malaria,” Microbes and Infection, vol. 1, no. 12, pp. 961–968, 1999. View at Publisher · View at Google Scholar · View at Scopus
  60. J. Li, W.-L. Chang, G. Sun et al., “Intercellular adhesion molecule 1 is important for the development of severe experimental malaria but is not required for leukocyte adhesion in the brain,” The Journal of Investigative Medicine, vol. 51, no. 3, pp. 128–140, 2003. View at Google Scholar · View at Scopus
  61. W. C. Aird, “Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms,” Circulation Research, vol. 100, no. 2, pp. 158–173, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. L. E. Craig, J. P. Spelman, J. D. Strandberg, and M. C. Zink, “Endothelial cells from diverse tissues exhibit differences in growth and morphology,” Microvascular Research, vol. 55, no. 1, pp. 65–76, 1998. View at Publisher · View at Google Scholar · View at Scopus
  63. M. R. Gillrie, G. Krishnegowda, K. Lee et al., “Src-family kinase-dependent disruption of endothelial barrier function by Plasmodium falciparum merozoite proteins,” Blood, vol. 110, no. 9, pp. 3426–3435, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. P. Fu, P. V. Usatyuk, A. Lele et al., “c-Abl mediated tyrosine phosphorylation of paxillin regulates LPS-induced endothelial dysfunction and lung injury,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 308, no. 10, pp. L1025–L1038, 2015. View at Publisher · View at Google Scholar
  65. F. Wessel, M. Winderlich, M. Holm et al., “Leukocyte extravasation and vascular permeability are each controlled in vivo by different tyrosine residues of VE-cadherin,” Nature Immunology, vol. 15, no. 3, pp. 223–230, 2014. View at Publisher · View at Google Scholar · View at Scopus
  66. P. F. Piguet, C. Da Laperrousaz, C. Vesin, F. Tacchini-Cottier, G. Senaldi, and G. E. Grau, “Delayed mortality and attenuated thrombocytopenia associated with severe malaria in urokinase- and urokinase receptor-deficient mice,” Infection and Immunity, vol. 68, no. 7, pp. 3822–3829, 2000. View at Publisher · View at Google Scholar · View at Scopus
  67. R. T. Amison, S. Momi, A. Morris et al., “RhoA signaling through platelet P2Y(1) receptor controls leukocyte recruitment in allergic mice,” Journal of Allergy and Clinical Immunology, vol. 135, no. 2, pp. 528–538, 2014. View at Publisher · View at Google Scholar · View at Scopus
  68. R. F. Xie, P. Hu, Z. C. Wang et al., “Platelet-derived microparticles induce polymorphonuclear leukocyte-mediated damage of human pulmonary microvascular endothelial cells,” Transfusion, vol. 55, no. 5, pp. 1051–1057, 2015. View at Publisher · View at Google Scholar · View at Scopus
  69. C. Alves, J.-T. Chen, N. Patel et al., “Extracorporeal membrane oxygenation for refractory acute respiratory distress syndrome in severe malaria,” Malaria Journal, vol. 12, article 306, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. T. W. Yeo, D. A. Lampah, R. Gitawati et al., “Impaired nitric oxide bioavailability and L-arginine-reversible endothelial dysfunction in adults with Falciparum malaria,” The Journal of Experimental Medicine, vol. 204, no. 11, pp. 2693–2704, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. T. P. Abreu, L. S. Silva, C. M. Takiya et al., “Mice rescued from severe malaria are protected against renal injury during a second kidney insult,” PLoS ONE, vol. 9, no. 4, Article ID e93634, 2014. View at Publisher · View at Google Scholar · View at Scopus
  72. A. E. P. Frosch and C. C. John, “Immunomodulation in Plasmodium falciparum malaria: experiments in nature and their conflicting implications for potential therapeutic agents,” Expert Review of Anti-Infective Therapy, vol. 10, no. 11, pp. 1343–1356, 2012. View at Publisher · View at Google Scholar · View at Scopus
  73. G. Watt, K. Jongsakul, and R. Ruangvirayuth, “A pilot study of N-acetylcysteine as adjunctive therapy for severe malaria,” QJM, vol. 95, no. 5, pp. 285–290, 2002. View at Publisher · View at Google Scholar · View at Scopus
  74. A. K. Boggild, S. Krudsood, S. N. Patel et al., “Use of peroxisome proliferator-activated receptor γ agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial,” Clinical Infectious Diseases, vol. 49, no. 6, pp. 841–849, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. L. Serghides, C. R. McDonald, Z. Lu et al., “PPARγ agonists improve survival and neurocognitive outcomes in experimental cerebral malaria and induce neuroprotective pathways in human malaria,” PLoS Pathogens, vol. 10, no. 3, Article ID e1003980, 2014. View at Publisher · View at Google Scholar · View at Scopus
  76. T. W. Yeo, D. A. Lampah, I. Rooslamiati et al., “A randomized pilot study of L-arginine infusion in severe Falciparum malaria: preliminary safety, efficacy and pharmacokinetics,” PLoS ONE, vol. 8, no. 7, Article ID e69587, 2013. View at Publisher · View at Google Scholar · View at Scopus
  77. A. M. Dondorp, K. Silamut, P. Charunwatthana et al., “Levamisole inhibits sequestration of infected red blood cells in patients with falciparum malaria,” Journal of Infectious Diseases, vol. 196, no. 3, pp. 460–466, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. A. Dondorp, F. Nosten, K. Stepniewska, N. Day, and N. White, “Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial,” The Lancet, vol. 366, no. 9487, pp. 717–725, 2005. View at Google Scholar
  79. M. E. Sarciron, C. Saccharin, A. F. Petavy, and F. Peyron, “Effects of artesunate, dihydroartemisinin, and an artesunate-dihydroartemisinin combination against Toxoplasma gondii,” The American Journal of Tropical Medicine and Hygiene, vol. 62, no. 1, pp. 73–76, 2000. View at Google Scholar · View at Scopus
  80. T. Efferth, H. Dunstan, A. Sauerbrey, H. Miyachi, and C. R. Chitambar, “The anti-malarial artesunate is also active against cancer,” International Journal of Oncology, vol. 18, no. 4, pp. 767–773, 2001. View at Google Scholar · View at Scopus
  81. S. J. F. Kaptein, T. Efferth, M. Leis et al., “The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo,” Antiviral Research, vol. 69, no. 2, pp. 60–69, 2006. View at Publisher · View at Google Scholar · View at Scopus
  82. J. Wang, H. Zhou, J. Zheng et al., “The antimalarial artemisinin synergizes with antibiotics to protect against lethal live Eschenchia coli challenge by decreasing proinflammatory cytokine release,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 7, pp. 2420–2427, 2006. View at Publisher · View at Google Scholar · View at Scopus
  83. M. C. Souza, F. H. Paixao, F. K. Ferraris, I. Ribeiro, and M. Henriques, “Artesunate exerts a direct effect on endothelial cell activation and NF-kappaB translocation in a mechanism independent of plasmodium killing,” Malaria Research and Treatment, vol. 2012, Article ID 679090, 12 pages, 2012. View at Publisher · View at Google Scholar
  84. R. Srinivas, R. Agarwal, and D. Gupta, “Severe sepsis due to severe falciparum malaria and leptospirosis co-infection treated with activated protein C,” Malaria Journal, vol. 6, article 42, 2007. View at Publisher · View at Google Scholar · View at Scopus
  85. C. Guitton, A. Cottereau, N. Gérard et al., “Protective cross talk between activated protein C and TNF signaling in vascular endothelial cells: implication of EPCR, noncanonical NF-κB, and ERK1/2 MAP kinases,” American Journal of Physiology—Cell Physiology, vol. 300, no. 4, pp. C833–C842, 2011. View at Publisher · View at Google Scholar · View at Scopus
  86. M. Riewald and R. A. Schuepbach, “Protective signaling pathways of activated protein C in endothelial cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 1, pp. 1–3, 2008. View at Publisher · View at Google Scholar · View at Scopus
  87. J. Dormoi, S. Briolant, A. Pascual, C. Desgrouas, C. Travaillé, and B. Pradines, “Improvement of the efficacy of dihydroartemisinin with atorvastatin in an experimental cerebral malaria murine model,” Malaria Journal, vol. 12, article 302, 2013. View at Publisher · View at Google Scholar · View at Scopus
  88. P. A. Reis, V. Estato, T. I. da Silva et al., “Statins decrease neuroinflammation and prevent cognitive impairment after cerebral malaria,” PLoS Pathogens, vol. 8, no. 12, Article ID e1003099, 2012. View at Publisher · View at Google Scholar · View at Scopus
  89. G. Weitz-Schmidt, K. Welzenbach, V. Brinkmann et al., “Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site,” Nature Medicine, vol. 7, no. 6, pp. 687–692, 2001. View at Publisher · View at Google Scholar · View at Scopus
  90. Z. Taoufiq, P. Pino, N. N'Dilimabaka et al., “Atorvastatin prevents Plasmodium falciparum cytoadherence and endothelial damage,” Malaria Journal, vol. 10, article 52, 2011. View at Publisher · View at Google Scholar · View at Scopus
  91. S.-Y. Ou, H. Chu, P.-W. Chao et al., “Effect of the use of low and high potency statins and sepsis outcomes,” Intensive Care Medicine, vol. 40, no. 10, pp. 1509–1517, 2014. View at Publisher · View at Google Scholar · View at Scopus
  92. C. A. Finney, C. A. Hawkes, D. C. Kain et al., “S1P is associated with protection in human and experimental cerebral malaria,” Molecular Medicine, vol. 17, no. 7-8, pp. 717–725, 2011. View at Google Scholar
  93. M. C. Souza, J. D. Silva, T. A. Padua et al., “Mesenchymal stromal cell therapy attenuated lung and kidney injury but not brain damage in experimental cerebral malaria,” Stem Cell Research & Therapy, vol. 6, pp. 102–117, 2015. View at Publisher · View at Google Scholar
  94. A. Nacer, A. Claes, A. Roberts et al., “Discovery of a novel and conserved Plasmodium falciparum exported protein that is important for adhesion of PfEMP1 at the surface of infected erythrocytes,” Cellular Microbiology, vol. 17, no. 8, pp. 1205–1216, 2015. View at Publisher · View at Google Scholar
  95. W. Solomon, N. O. Wilson, L. Anderson et al., “Neuregulin-1 attenuates mortality associated with experimental cerebral malaria,” Journal of Neuroinflammation, vol. 11, article 9, 2014. View at Publisher · View at Google Scholar · View at Scopus
  96. R. Schweizer, P. Kamat, D. Schweizer et al., “Bone marrow-derived mesenchymal stromal cells improve vascular regeneration and reduce leukocyte-endothelium activation in critical ischemic murine skin in a dose-dependent manner,” Cytotherapy, vol. 16, no. 10, pp. 1345–1360, 2014. View at Publisher · View at Google Scholar · View at Scopus
  97. T. Maron-Gutierrez, J. G. Laffey, P. Pelosi, and P. R. M. Rocco, “Cell-based therapies for the acute respiratory distress syndrome,” Current Opinion in Critical Care, vol. 20, no. 1, pp. 122–131, 2014. View at Publisher · View at Google Scholar · View at Scopus
  98. A. Ryan and C. Godson, “Lipoxins: regulators of resolution,” Current Opinion in Pharmacology, vol. 10, no. 2, pp. 166–172, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. O. Haworth, M. Cernadas, R. Yang, C. N. Serhan, and B. D. Levy, “Resolvin E1 regulates interleukin 23, interferon-γ and lipoxin A4 to promote the resolution of allergic airway inflammation,” Nature Immunology, vol. 9, no. 8, pp. 873–879, 2008. View at Publisher · View at Google Scholar · View at Scopus
  100. M. M.-Y. Chan and A. R. Moore, “Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production,” The Journal of Immunology, vol. 184, no. 11, pp. 6418–6426, 2010. View at Publisher · View at Google Scholar · View at Scopus
  101. S. Fiorucci, E. Distrutti, A. Mencarelli et al., “Evidence that 5-lipoxygenase and acetylated cyclooxygenase 2-derived eicosanoids regulate leukocyte-endothelial adherence in response to aspirin,” British Journal of Pharmacology, vol. 139, no. 7, pp. 1351–1359, 2003. View at Publisher · View at Google Scholar · View at Scopus
  102. N. Shryock, C. McBerry, R. M. S. Gonzalez, S. Janes, F. T. M. Costa, and J. Aliberti, “Lipoxin A4 and 15-epi-lipoxin A4 protect against experimental cerebral malaria by inhibiting IL-12/IFN-γ in the brain,” PLoS ONE, vol. 8, no. 4, Article ID e61882, 2013. View at Publisher · View at Google Scholar · View at Scopus
  103. Y.-F. Wang, Y.-T. Gu, G.-H. Qin, L. Zhong, and Y.-N. Meng, “Curcumin ameliorates the permeability of the blood-brain barrier during hypoxia by upregulating heme oxygenase-1 expression in brain microvascular endothelial cells,” Journal of Molecular Neuroscience, vol. 51, no. 2, pp. 344–351, 2013. View at Publisher · View at Google Scholar · View at Scopus
  104. C.-Y. Lu, Y.-C. Yang, C.-C. Li, K.-L. Liu, C.-K. Lii, and H.-W. Chen, “Andrographolide inhibits TNFα-induced ICAM-1 expression via suppression of NADPH oxidase activation and induction of HO-1 and GCLM expression through the PI3K/Akt/Nrf2 and PI3K/Akt/AP-1 pathways in human endothelial cells,” Biochemical Pharmacology, vol. 91, no. 1, pp. 40–50, 2014. View at Publisher · View at Google Scholar · View at Scopus
  105. A. Belhaj, L. Dewachter, F. Kerbaul et al., “Heme oxygenase-1 and inflammation in experimental right ventricular failure on prolonged overcirculation-induced pulmonary hypertension,” PLoS ONE, vol. 8, no. 7, Article ID e69470, 2013. View at Publisher · View at Google Scholar · View at Scopus
  106. A. Pamplona, A. Ferreira, J. Balla et al., “Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria,” Nature Medicine, vol. 13, no. 6, pp. 703–710, 2007. View at Publisher · View at Google Scholar · View at Scopus
  107. E. Seixas, R. Gozzelino, Â. Chora et al., “Heme oxygenase-1 affords protection against noncerebral forms of severe malaria,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 37, pp. 15837–15842, 2009. View at Publisher · View at Google Scholar · View at Scopus
  108. L. J. de Moura Carvalho, A. da Silva Moreira, C. T. Daniel-Ribeiro, and Y. C. Martins, “Vascular dysfunction as a target for adjuvant therapy in cerebral malaria,” Memorias do Instituto Oswaldo Cruz, vol. 109, no. 5, pp. 577–588, 2014. View at Publisher · View at Google Scholar · View at Scopus
  109. T. W. Yeo, D. A. Lampah, E. Kenangalem et al., “Decreased endothelial nitric oxide bioavailability, impaired microvascular function, and increased tissue oxygen consumption in children with falciparum malaria,” The Journal of Infectious Diseases, vol. 210, no. 10, pp. 1627–1632, 2014. View at Publisher · View at Google Scholar · View at Scopus
  110. M. Hawkes, R. O. Opoka, S. Namasopo et al., “Inhaled nitric oxide for the adjunctive therapy of severe malaria: protocol for a randomized controlled trial,” Trials, vol. 12, article 176, 2011. View at Publisher · View at Google Scholar · View at Scopus
  111. B. Bergmark, R. Bergmark, P. D. Beaudrap et al., “Inhaled nitric oxide and cerebral malaria: basis of a strategy for buying time for pharmacotherapy,” Pediatric Infectious Disease Journal, vol. 31, no. 12, pp. e250–e254, 2012. View at Publisher · View at Google Scholar · View at Scopus
  112. C. Bogdan, “Nitric oxide synthase in innate and adaptive immunity: an update,” Trends in Immunology, vol. 36, no. 3, pp. 161–178, 2015. View at Publisher · View at Google Scholar · View at Scopus
  113. P. Cabrales, G. M. Zanini, D. Meays, J. A. Frangos, and L. J. M. Carvalho, “Nitric oxide protection against murine cerebral malaria is associated with improved cerebral microcirculatory physiology,” Journal of Infectious Diseases, vol. 203, no. 10, pp. 1454–1463, 2011. View at Publisher · View at Google Scholar · View at Scopus
  114. G. M. Zanini, P. Cabrales, W. Barkho, J. A. Frangos, and L. J. M. Carvalho, “Exogenous nitric oxide decreases brain vascular inflammation, leakage and venular resistance during Plasmodium berghei ANKA infection in mice,” Journal of Neuroinflammation, vol. 8, article 66, 2011. View at Publisher · View at Google Scholar · View at Scopus
  115. J. Lou, R. Lucas, and G. E. Grau, “Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans,” Clinical Microbiology Reviews, vol. 14, no. 4, pp. 810–820, 2001. View at Publisher · View at Google Scholar · View at Scopus
  116. J. B. de Souza, J. C. R. Hafalla, E. M. Riley, and K. N. Couper, “Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease,” Parasitology, vol. 137, no. 5, pp. 755–772, 2010. View at Publisher · View at Google Scholar · View at Scopus
  117. A. G. Craig, G. E. Grau, C. Janse et al., “The role of animal models for research on severe malaria,” PLoS Pathogens, vol. 8, no. 2, Article ID e1002401, 2012. View at Publisher · View at Google Scholar · View at Scopus
  118. L. J. M. Carvalho, “Murine cerebral malaria: how far from human cerebral malaria?” Trends in Parasitology, vol. 26, no. 6, pp. 271–272, 2010. View at Publisher · View at Google Scholar · View at Scopus